Fibroblast Growth Factor 23
Showing 1 - 25 of >10,000
Fibrous Dysplasia Of Bone Trial run by the National Institute of Dental and Craniofacial Research (NIDCR) (Burosumab)
Not yet recruiting
- Fibrous Dysplasia Of Bone
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Fibroblast Growth Factor 23 and Sclerostin in Relation to
Not yet recruiting
- COVID-19
- Calcium
- +3 more
-
Aswan, EgyptAswan University hospital
Mar 11, 2022
Fibroblast Growth Factor 23 in Chronic Respiratory Failure
Not yet recruiting
- Chronic Respiratory Failure
- Dosage
- Cardiac echography
- (no location specified)
Feb 17, 2022
Fibroblast Growth Factor 23 and Hypertensive Disorder
Recruiting
- Hypertension, Pregnancy-Induced
-
Guangzhou, Guangdong, ChinaObstetrics and Gynechology Department of the 1st affiliated hosp
Sep 5, 2021
Fibroblast Growth Factor 23, Anemia, CKD Trial in Córdoba
Active, not recruiting
- Fibroblast Growth Factor 23
- +2 more
-
Córdoba, SpainHospital Universitario Reina Sofia
Apr 27, 2022
Chronic Kidney Disease Trial in France (Plasma osteoprotegerin level, Plasma fibroblast growth factor 23 level, Vascular
Recruiting
- Chronic Kidney Disease
- Plasma osteoprotegerin level
- +2 more
-
Castelnau Le Lez, France
- +4 more
Apr 13, 2022
Chronic Kidney Disease Trial in Montpellier, Saint-Jean-de-Védas (Plasma osteoprotegerin level, Plasma fibroblast growth factor
Recruiting
- Chronic Kidney Disease
- Plasma osteoprotegerin level
- +2 more
-
Montpellier, France
- +6 more
Dec 31, 2021
FGF23 as a Marker of Acute Kidney Injury
Recruiting
- Acute Kidney Injury
- Kidney Ischemia
- Plasmatic Fibroblast Growth Factor-23 by means of ELISA
-
Santiago, ChileHospital Clinic Universidad de Chile
Dec 30, 2020
Healthy, Chronic Kidney Disease Trial in Birmingham (Diet)
Completed
- Healthy
- Chronic Kidney Disease
- Diet
-
Birmingham, AlabamaUniversity of Alabama
Mar 10, 2021
Selected Factors on Cardiovascular System in Chronic Kidney
Completed
- Atherosclerosis of Artery
- +4 more
- laboratory parameters - complete blood count
- +23 more
-
Poznań, PolandPoznan University of Medical Sciences
Jan 25, 2022
Serum Fibroblast Growth Factor-21 Levels During Prolonged
Completed
- Fibroblast Growth Factor-21
- Fasting
- 12 hour fasting for 29 days
-
Ankara, TurkeyHacettepe University Nutrition and Dietetics Department
Mar 29, 2023
Fibroblast Growth Factor 21, Tast Perference Trial (Fibroblast growth factor 21 infusion, Placebo infusion (saline))
Active, not recruiting
- Fibroblast Growth Factor 21
- Tast Perference
- Fibroblast growth factor 21 infusion
- Placebo infusion (saline)
-
Hellerup, DenmarkAmalie R Lanng
Nov 21, 2022
NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)
Completed
- NAFLD
- Soy isoflavone
- Placebo
-
Ahvaz, Khuzestan, Iran, Islamic Republic ofAsal Neshatbini Tehrani
Oct 24, 2023
Healthy Trial in Frederiksberg (Sucrose, Sucrose + protein, Sucrose + fat)
Completed
- Healthy
- Sucrose
- +2 more
-
Frederiksberg, DenmarkDepartment of Nutrition, Exercise and Sports, University of Cope
Mar 30, 2022
Gestational Diabetes Trial in ChiangMai (blood draw)
Active, not recruiting
- Gestational Diabetes
- blood draw
-
ChiangMai, ThailandMaharaj Nakorn ChiangMai Hospital
Dec 1, 2022
Bladder Transitional Cell Carcinoma, Bladder Cancer, Fibroblast Growth Factor Receptor Trial (Infigratinib)
Withdrawn
- Bladder Transitional Cell Carcinoma
- +2 more
- (no location specified)
Aug 8, 2022
Fasting Trial in Boston (oral carbohydrate challenge)
Active, not recruiting
- Fasting
- oral carbohydrate challenge
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Jul 18, 2022
Markers of Metabolism and Vascular Access in ESRD
Not yet recruiting
- Disorders of Calcium and Bone Metabolism
- vascular acess
- (no location specified)
May 2, 2023
Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A, Fibroblast Growth Factor Basic Form Measurement, FLT3 Internal
Recruiting
- Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A
- +4 more
- Azacitidine
- +2 more
-
Chicago, IllinoisNorthwestern University
Apr 30, 2021
Locally Advanced Gastrointestinal Stromal Tumor, Locally Advanced Sarcoma, Metastatic Gastrointestinal Stromal Tumor Trial in
Recruiting
- Locally Advanced Gastrointestinal Stromal Tumor
- +7 more
- Biopsy
- +4 more
-
Duarte, California
- +17 more
Feb 2, 2023
Albuminuria Trial in Baltimore (Higher phosphorus period, Lower phosphorus period)
Completed
- Albuminuria
- Higher phosphorus period
- Lower phosphorus period
-
Baltimore, MarylandProhealth Clinical Research Unit
Feb 26, 2019
Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)
Recruiting
- Urothelial Carcinoma
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 8, 2023
